fotemustine has been researched along with Recrudescence in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Beige, A; Borsotti, F; Farah, W; Ghiringhelli, F; Ilie, SM; Lecuelle, J; Mazilu, I; Truc, G; Truntzer, C; Vincent, J | 1 |
| Bulzonetti, N; D'Elia, A; De Felice, F; Musio, D; Salvati, M; Tombolini, V | 1 |
| Bellu, L; D'Avella, D; Della Puppa, A; Farina, M; Fiduccia, P; Lombardi, G; Pambuku, A; Zagonel, V | 1 |
| Corso, A; Lazzarino, M; Mangiacavalli, S; Pica, G; Varettoni, M | 1 |
| Amistà , P; Bianchini, C; Blatt, V; Brandes, AA; Ermani, M; Faedi, M; Franceschi, E; Gardiman, M; Labianca, R; Reni, M; Santoro, A; Tosoni, A | 1 |
| Dargenio, M; Di Renzo, N; Forese, P; Matera, R; Pennese, E; Vergine, C | 1 |
| Ardiet, C; Berger, E; Bouafia, F; Coiffier, B; Dumontet, C; Guyotat, D; Jaubert, J; Lucas, C; Sebban, C; Tranchand, B | 1 |
2 trial(s) available for fotemustine and Recrudescence
| Article | Year |
|---|---|
Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Humans; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Recurrence; Temozolomide | 2009 |
Clinical and pharmacokinetic phase II study of fotemustine in refractory and relapsing multiple myeloma patients.
Topics: Aged; Antineoplastic Agents; Disease Progression; Disease-Free Survival; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Multiple Myeloma; Neutropenia; Nitrosourea Compounds; Organophosphorus Compounds; Outpatients; Prognosis; Recurrence; Sepsis; Thrombocytopenia | 2003 |
5 other study(ies) available for fotemustine and Recrudescence
| Article | Year |
|---|---|
Efficacy of Chemotherapy Plus Bevacizumab in Recurrent Glioblastoma Multiform: A Real-life Study.
Topics: Bevacizumab; Chronic Disease; Cytotoxins; Glioblastoma; Humans; Irinotecan; Recurrence; Retrospective Studies; Temozolomide | 2022 |
Low-dose fotemustine as second-line chemotherapy for recurrent glioblastoma multiforme.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Disease-Free Survival; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Recurrence | 2013 |
Clinical outcome of an alternative fotemustine schedule in elderly patients with recurrent glioblastoma: a mono-institutional retrospective study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Brain Neoplasms; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Drug Administration Schedule; Female; Humans; Male; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Recurrence; Retrospective Studies; Survival Analysis; Temozolomide; Treatment Outcome; Tumor Suppressor Proteins | 2016 |
Efficacy and safety of fotemustine for the treatment of relapsed and refractory multiple myeloma patients.
Topics: Adult; Antineoplastic Agents; Female; Humans; Male; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Organophosphorus Compounds; Recurrence | 2009 |
Complete response induced by fotemustine given as single agent in a patient with primary central nervous system non-Hodgkin aggressive lymphoma relapsed after high-dose chemotherapy and autologous stem cell support.
Topics: Adult; Antineoplastic Agents; Central Nervous System Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Therapy; Humans; Lymphoma, Non-Hodgkin; Male; Nitrosourea Compounds; Organophosphorus Compounds; Recurrence; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome | 2011 |